Related Experiment Video
Updated: Jul 19, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Truncated midkine correlates with sensitivity to anticancer drugs and malignancy in human tumor cell line
Natsuyo Akuzawa1, Shigenori Nobata, Takao Shinozawa
1Department of Biological and Chemical Engineering, Faculty of Engineering, Gunma University, Kiryu, Gunma, Japan.
Abstract:
Midkine (MK) is a heparin binding growth factor having functions of neurite-outgrowth, mitogenesis and tissue repair. This molecule is involved in tumor growth and metastasis. The MK molecule consists of five exons, but there is a truncated isoform, lacking exon 3. We established SW13 cells transfected with the human truncated MK cDNA. These cells were induced to undergo apoptosis by anticancer agents, cisplatin, etoposide (ETP), mitomycin C (MMC) and paclitaxel (PAX). Truncated midkine (tMK) suppressed cell death and helped the cells to be viable. When the cells were cultured on dishes coated with extracellular matrix molecules, spontaneous detachment occurred in the tMK expressing cells. Also tMK enhanced cell invasion. These results suggest that expression of tMK has cell-protective functions and plays important roles in carcinogenesis and malignancy. Furthermore, it is suggested that tMK has a greater ability of malignant transformation than full-length MK. Whether tMK is expressed or not will be useful information for improving cancer chemotherapy.
Insights
Truncated midkine (tMK) offers cell-protective functions, suppressing apoptosis and enhancing invasion, suggesting a greater role in malignant transformation than full-length midkine (MK). This finding is crucial for improving cancer chemotherapy strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Midkine (MK) is a growth factor implicated in tumor progression and metastasis.
- A truncated isoform of MK (tMK), lacking exon 3, has been identified.
Purpose of the Study:
- To investigate the functional role of truncated midkine (tMK) in cancer.
- To determine if tMK influences cancer cell survival, invasion, and malignant transformation.
Main Methods:
- SW13 cells were transfected with human truncated MK cDNA.
- Cells expressing tMK were treated with anticancer agents (cisplatin, etoposide, mitomycin C, paclitaxel) to induce apoptosis.
- Cell viability and detachment on extracellular matrix were assessed.
- Cell invasion assays were performed.
Main Results:
- Truncated midkine (tMK) significantly suppressed apoptosis induced by anticancer agents, promoting cell viability.
- tMK expression led to spontaneous cell detachment when cultured on extracellular matrix.
- tMK enhanced cancer cell invasion capabilities.
- tMK demonstrated a potentially greater role in malignant transformation compared to full-length MK.
Conclusions:
- Truncated midkine (tMK) exhibits potent cell-protective functions, contributing to cancer cell survival.
- tMK expression promotes key features of malignancy, including invasion and potentially enhanced transformation.
- Assessing tMK expression may provide valuable insights for optimizing cancer chemotherapy.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
